Total Funding
90
49
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
-34 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
40269
Thrombolex designs, develops, manufactures, and distributes innovative endovascular catheters.
- Michael J. Cerminaro: President and COOPast Role: Sound Harbor Partners, Partner & Co-Founder
- Brian Firth: CSO
About the Company
Thrombolex designs, develops, manufactures, and distributes innovative endovascular catheters. The company's mission is to create innovative endovascular catheters for use in the treatment of patients with arterial and venous thromboembolic (A+VTE) conditions. It allows for the selective infusion of the physician, specified fluids, including
thrombolytics, into precise locations in the patient’s peripheral vasculature. Thereby treating the thrombus more efficiently in less time, using lower doses of thrombolytic drugs, thus reducing costs.
Thrombolex was founded in 2016 by Michael J. Cerminaro.
